Citation: Kapadia SN, Eckhardt BJ, Leff JA, Fong C, Mateu-Gelabert P, Marks KM, Aponte-Melendez Y, Schackman BR. Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial. Drug Alcohol Depend Rep. 2022 Dec;5:100109. doi: 10.1016/j.dadr.2022.100109. Epub 2022 Oct 7. PMID: 36644226; PMCID: PMC9836210.